An investigational vaccine appears generally well tolerated and effective against the most common strain of norovirus, reducing the main symptoms of the gastrointestinal infection, vomiting and/or diarrhea, by 52 percent.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/1...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/1...